Literature DB >> 22343786

Incidence and presentation of reported coeliac disease in Cardiff and the Vale of Glamorgan: the next 10 years.

Joanna J Hurley1, Bee Lee, Jeffrey K Turner, Amanda Beale, Huw R Jenkins, Gillian L Swift.   

Abstract

OBJECTIVE: To determine whether there is a continued increase in the incidence of coeliac disease (CD) in the population of Cardiff and the Vale of Glamorgan between 1996 and 2005 compared with previous data for 1981-1995, and to describe the presenting features during this time.
DESIGN: Retrospective case-finding study using pathology, dietetic and clinical records held in hospitals and general practice within Cardiff and the Vale of Glamorgan. All local consultants including those at private hospitals were contacted. Incidence rates were calculated using the Welsh Assembly Government's mid-year estimates.
RESULTS: In total, 347 newly diagnosed cases of CD (42 children, 305 adults) were detected. Compared with previous published data, incidence rates in adults per 100 000 have increased from 3.08 at the end of 1995 to 11.13 in 2005. In children, the disease incidence has trebled to 6.89 per 100 000. There have been some changes in presenting symptoms, with a marked preponderance of abdominal pain and bloating in women (P<0.05). There has been a 14-fold increase in the numbers of patients undergoing coeliac serology testing from 1996 to 2005, associated with an increased absolute number of new cases. However, the proportion of new cases diagnosed compared with numbers of serological tests performed decreased from 5.8 to 1.1%.
CONCLUSION: The incidence of CD in children and adults has markedly increased. One of the most striking features of our data in adult CD is the increasing frequency of abdominal pain and bloating in the female cohort. Incorporation of antibody testing into clinical guidelines is likely to result in a wider spectrum of individuals with nonspecific gastrointestinal symptoms being investigated and diagnosed with CD in the future.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22343786     DOI: 10.1097/MEG.0b013e328350f888

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  5 in total

Review 1.  The diagnosis and treatment of celiac disease.

Authors:  Detlef Schuppan; Klaus-Peter Zimmer
Journal:  Dtsch Arztebl Int       Date:  2013-12-06       Impact factor: 5.594

2.  Incidence and distribution of coeliac disease in Campania (Italy): 2011-2013.

Authors:  Fabiana Zingone; Joe West; Renata Auricchio; Rosa Maria Bevilacqua; Guido Bile; Patrizia Borgheresi; Maria Erminia Bottiglieri; Mariano Caldore; Giuseppe Capece; Maria Cristina Caria; Antonio Crudele; Rosario Cuomo; Maria Lucia Garofano; Nicola Giardullo; Antonietta Gerarda Gravina; Luigi Greco; Patrizia Iannotta; Paolo Kosova; Roberto Lamanda; Basilio Malamisura; Riccardo Marmo; Gianfranco Napoli; Gerardo Nardone; Maria Pacelli; Filomena Pascarella; Elisabetta Riccio; Gabriele Riegler; Antonio Rispo; Alba Rocco; Marco Romano; Ottavio Saffiotti; Paola Saviano; Italo Sorrentini; Pietro Speranza; Carlo Tolone; Raffaella Tortora; Riccardo Troncone; Carolina Ciacci
Journal:  United European Gastroenterol J       Date:  2015-04       Impact factor: 4.623

3.  Does gluten free diet have more implications than treatment of celiac disease?

Authors:  Ramin Talaie
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2015

4.  Validation of an algorithm to identify children with biopsy-proven celiac disease from within health administrative data: An assessment of health services utilization patterns in Ontario, Canada.

Authors:  Jason Chan; David R Mack; Douglas G Manuel; Nassim Mojaverian; Joseph de Nanassy; Eric I Benchimol
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

5.  Two waves of coeliac disease incidence in Sweden: a nationwide population-based cohort study from 1990 to 2015.

Authors:  David Bergman; James King; Benjamin Lebwohl; Mark S Clements; Bjorn Roelstraete; Gilaad G Kaplan; Peter Hr Green; Joseph A Murray; Jonas F Ludvigsson
Journal:  Gut       Date:  2021-07-28       Impact factor: 31.793

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.